Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. DKSH Holding AG
  6. News
  7. Summary
    DKSH   CH0126673539

DKSH HOLDING AG

(DKSH)
  Report
Delayed Swiss Exchange  -  11:31:51 2023-01-26 am EST
75.95 CHF   +1.88%
01:44aDKSH Wins Distribution Rights for Dow Consumer's Products
MT
01:13aDksh : Started a new Partnership With Dow Consumer Solutions in Southeast Asia, Australia, and New Zealand
PU
01/03Change in DKSH's Executive Committee
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

DKSH Continues Strengthening its Healthcare Own Brands Business With the Acquisition of two Brands From Eisai

11/07/2022 | 01:03am EST

DKSH Management Ltd. / Key word(s): Acquisition
DKSH Continues Strengthening its Healthcare Own Brands Business With the Acquisition of two Brands From Eisai

07.11.2022 / 07:00 CET/CEST


Media release

DKSH has signed an agreement to acquire two pharma brands from Eisai for nine markets in Asia Pacific. The acquisition fits in DKSH's strategy to grow in higher value-added segments and services and solidifies DKSH Healthcare’s leading position in the region.

Zurich, Switzerland, November 7, 2022 – DKSH has signed an agreement to purchase two well-known pharma brands, Myonal and Merislon, from Eisai in Thailand, Indonesia, the Philippines (Myonal only), Malaysia, Singapore, Taiwan (Merislon only), Myanmar, Cambodia, and Laos. Myonal is a muscle-relaxant which is used to treat neck-shoulder-arm syndrome and Merislon is approved to treat vertigo and dizziness associated with inner-ear disorders. Both brands are recognized among medical professionals in Asia Pacific and have established safety profiles.

With the acquisition, DKSH continues its strategy to expand its Healthcare Own Brands portfolio and to grow in Asia Pacific. The acquired portfolio generates net sales of over CHF 15 million. DKSH already markets these products for Eisai in most of the nine Asian markets and with the acquisition now becomes full brand owner. DKSH will continue to outsource production to established manufacturers for this portfolio.

Bijay Singh, Head Business Unit Healthcare at DKSH, commented: “This acquisition is another indicator of our commitment to growing our Own Brands portfolio. We are excited about this development since it helps us solidifying our leading position in Asia Pacific.”

About DKSH
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 33,100 specialists, generating net sales of CHF 11.1 billion in 2021. The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With around 7,920 specialists, the Business Unit generated net sales of CHF 5.6 billion in 2021. www.dksh.com/hec

For more information please contact:

DKSH Holding Ltd.
Till Leisner
Head, Group Investor & Media Relations, Sustainability
Phone +41 44 386 7315
till.leisner@dksh.com

Demet Biçer
Manager, Group Media Relations
Phone +41 44 386 7117
demet.bicer@dksh.com



End of Media Release


Language: English
Company: DKSH Management Ltd.
Wiesenstrasse 8
8008 Zurich
Switzerland
Phone: 044 386 72 72
E-mail: media@dksh.com
Internet: www.dksh.com
ISIN: CH0126673539
Valor: 12667353
Listed: SIX Swiss Exchange
EQS News ID: 1480087

 
End of News EQS News Service

1480087  07.11.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1480087&application_name=news&site_id=zonebourse_sftp

ę EQS 2022
All news about DKSH HOLDING AG
01:44aDKSH Wins Distribution Rights for Dow Consumer's Products
MT
01:13aDksh : Started a new Partnership With Dow Consumer Solutions in Southeast Asia, Australia,..
PU
01/03Change in DKSH's Executive Committee
EQ
01/03DKSH Holding AG Announces Resignation of Terry Seremetis as Head Business Unit Consumer..
CI
2022DKSH sells its 25% stake in Swiss luxury watchmaker Bovet
RE
2022DKSH Exits Swiss Luxury Watchmaker Bovet Fleurier
MT
2022DKSH Sells its 25% Stake in Swiss Luxury Watchmaker Bovet
EQ
2022Pascal Raffy agreed to acquire 25% stake in Bovet Fleurier S.A. from DKSH Holding AG.
CI
2022DKSH Strikes Taiwan-focused Distribution Deal With SC Johnson's Babyganics Brand
MT
2022Dksh : Partners With SPLAT« to Offer Natural Oral Care Solutions in Malaysia
PU
More news
Analyst Recommendations on DKSH HOLDING AG
More recommendations
Financials
Sales 2022 11 381 M 12 350 M 12 350 M
Net income 2022 212 M 230 M 230 M
Net Debt 2022 150 M 163 M 163 M
P/E ratio 2022 23,6x
Yield 2022 2,81%
Capitalization 4 934 M 5 354 M 5 354 M
EV / Sales 2022 0,45x
EV / Sales 2023 0,42x
Nbr of Employees 31 160
Free-Float 49,3%
Chart DKSH HOLDING AG
Duration : Period :
DKSH Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DKSH HOLDING AG
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 75,95 CHF
Average target price 79,67 CHF
Spread / Average Target 4,89%
EPS Revisions
Managers and Directors
Stefan P. Butz Chief Executive Officer
Ido Wallach Chief Financial Officer
Marco Gadola Chairman
Sam Oh Chief Information Officer
Laurent Sigismondi Secretary, General Counsel & Head-Governance
Sector and Competitors
1st jan.Capi. (M$)
DKSH HOLDING AG6.20%5 264
CINTAS CORPORATION-3.27%44 395
TELEPERFORMANCE SE11.81%16 021
EDENRED SE-2.18%13 509
BUREAU VERITAS SA6.46%12 911
LG CORP.6.79%10 574